In a new study, a team led by scientists at The Scripps Research Institute (TSRI) tracked how a family of potent HIV-fighting antibodies develops over time. The research shows how a future vaccine might trigger the immune system to produce these antibodies more effectively.

Scientists from The Scripps Research Institute (TSRI) and the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have found a way to induce antibodies to fight a wide range of influenza subtypes—work that could one day eliminate the need for repeated seasonal flu shots.

Scripps Research and Rockefeller Scientists Work on Obesity Therapy as Proof-of-Principle.